Results 21 to 30 of about 47,543 (305)

Concurrent Chemoradiotherapy for Advanced Hypopharyngeal Cancer

Nippon Jibiinkoka Gakkai Kaiho, 2005
Chemotherapy has been shown to be most effective when delivered concurrently with radiation for the patients with advanced stage tumors. We conducted a concurrent chemoradiation using systemic infusion of cisplatin (CDDP) and 5-fluorouracil (5-FU).Thirty-nine patients with advanced hypopharyngeal cancer received one or two cycles of intravenous ...
Sohei, Endo, Shin, Suzuki, Kenzo, Tsuji, Yasuyuki, Nomura, Yugo, Noguchi, Akinori, Kida, Tsutomu, Saito, Yoshiaki, Tanaka   +7 more
openaire   +3 more sources

Survival of Patients With Cervical Cancer Treated With Definitive Radiotherapy or Concurrent Chemoradiotherapy According to Histological Subtype: A Systematic Review and Meta-Analysis

Frontiers in Medicine, 2022
BackgroundCervical cancer is a leading cause of morbidity and mortality for women worldwide. Different histopathological cervical cancer subtypes (i.e., adenocarcinoma/adenosquamous carcinoma, and squamous cell carcinoma) are all treated similarly with ...
Guorong Yao, Jian Qiu, Fengjia Zhu, Xiaoxie Wang   +3 more
doaj   +1 more source

Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers. [PDF]

, 2019
For long, the treatment of locoregionally advanced laryngeal and hypopharyngeal squamous cell cancers (SCC) consisted of either total laryngectomy (TL) or definitive radiotherapy (RT).
Argiris, Athanassios, Lefebvre, Jean Louis   +1 more
core   +2 more sources

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]

, 2013
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Arnold, Dirk, Brenner, Baruch, Galle, Peter R., Gockel, Ines, Klautke, Gunther, Lang, Hauke, Möhler, Markus, Roessler, Hans-Peter, Rödel, Claus, Schimanski, Carl Christoph, Schmidberger, Heinz, Thomaidis, Thomas, Trarbach, Tanja   +12 more
core   +1 more source

Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: A review of the National Cancer Database [PDF]

, 2017
For elderly patients with locally advanced esophageal cancer, therapeutic approaches and outcomes in a modern cohort are not well characterized. Patients ≥70 years old with clinical stage II and III esophageal cancer diagnosed between 1998 and 2012 were ...
Bradley, Jeffrey D, Kozower, Benjamin, Lockhart, A. Craig, Meyers, Bryan F, Parikh, Parag J, Perkins, Stephanie M, Puri, Varun, Roach, Michael C, Robinson, Cliff G, Samson, Pamela P, Vlacich, Gregory   +10 more
core   +2 more sources

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab

Frontiers in Oncology, 2021
BackgroundCisplatin-based concurrent chemoradiotherapy is standard of care for locally advanced head and neck cancers (LAHNC). Nedaplatin, lobaplatin and nimotuzumab have shown anti-cancer effect with less gastrointestinal toxicity and nephrotoxicity ...
Qiuji Wu, Chunmei Zhu, Shuyuan Zhang, Yunfeng Zhou, Yahua Zhong   +4 more
doaj   +1 more source

The role of adjuvant chemotherapy for patients with resected pancreatic cancer: Systematic review of randomized controlled trials and meta-analysis [PDF]

, 2007
Background: In patients undergoing surgery for resectable pancreatic cancer prognosis still remains poor. The role of adjuvant treatment strategies (including chemotherapy and chemoradiotherapy) following resection of pancreatic cancer remains ...
Bakkevold KE, Berger AC, Blackstock AW, Cress RD, Donna Pauler Ankerst, Gastrointestinal Tumour Study Group, Hochster HS, Kalser MH, Khanna A, Knaebel HP, Kosuge T, Luttges J, Oettle H, Ozols RF, Peto R, Regine WF, Stefan Boeck, Volker Heinemann   +17 more
core   +1 more source

Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study

Cancer Cell International, 2022
Background To determine whether concurrent chemotherapy is necessary during locoregional radiotherapy (RT) after palliative chemotherapy (PCT) in patients with de novo metastatic nasopharyngeal carcinoma (mNPC).
Shuo-Han Zheng, Yu-Tong Wang, Song-Ran Liu, Zi-Lu Huang, Guan-Nan Wang, Jin-Tao Lin, Shi-Rong Ding, Chen Chen, Yun-Fei Xia   +8 more
doaj   +1 more source

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer [PDF]

Radiation Oncology, 2009
La secuenciación óptima de la quimioterapia y la radioterapia después de la cirugía de mama se estudió en gran medida, pero sigue siendo controvertida. La quimio-radioterapia concurrente es un método valioso para el tratamiento adyuvante del cáncer de mama que se encuentra bajo un programa de investigación en curso en nuestro hospital.
Nabil Ismaili, Nawfel Mellas, O. Masbah, Sanaa Elmajjaoui, Samia Arifi, I. Bekkouch, Samir Ahid, Zakaria Bazid, Mehdi Tazi, Abdelouahed Er-Raki, Omar El Mesbahi, Noureddine Benjaafar, B.K. El Gueddari, Mohammed Ismaili, Saïd Afqir, Hassan Errihani   +15 more
openaire   +3 more sources

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma

Case Reports in Oncology, 2014
Little information is available about the usefulness of concurrent chemoradiotherapy for locally advanced thymic carcinoma due to a rare anterior mediastinal tumor.
Toshirou Fukushima, Kazunari Tateishi, Masayuki Hanaoka, Keiichirou Koiwai, Shigeru Sasaki, Tomonobu Koizumi   +5 more
doaj   +1 more source